Project description
Novel breast cancer diagnostic test for personalised treatment
Breast cancer (BC) is the most common cancer in women worldwide, but current diagnostic tests lack precision, often leading to misdiagnosis and inaccurate treatment. The goal of the EU-funded Multiplex8+ project is the development of a personalised and precise diagnostic test for early and late-stage BC. The test combines two patented multiplexed cancer diagnostic technologies: visualisation (RNA FISH) and RNA sequencing. The combination of these technologies will help to eliminate misdiagnosis and will enable a specific BC barcode system to suggest a particular personalised treatment and estimate its length and prognostic value. The current project stage involves establishing an accredited laboratory for clinical validation followed by the creation of the first high-value biotech company in Slovakia.
Fields of science
Programme(s)
Funding Scheme
SME-2b - SME Instrument (grant only and blended finance)Coordinator
841 04 Bratislava
Slovakia
See on map